Molecular Determinants Of Outcome For Metastatic Castration-Sensitive Prostate Cancer (Mcspc) With Addition Of Apalutamide (Apa) Or Placebo (Pbo) To Androgen Deprivation Therapy (Adt) In Titan.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要